TCR Term Policies

General Information



The Clinical Researcher considers only original communications. Prior and duplicate publications are not allowed. Publication of abstract under conference proceedings will not be considered as prior publication. It is the duty of the authors to inform the editor about all submissions and previous reports that might be regarded as prior or duplicate publication.

Manuscripts for publication will be considered on their individual merits. All manuscripts will be subjected to peer review. Normally manuscripts will be sent to at least two reviewers and their comments along with the editorial board’s decision will be forwarded to the contributor for further action. The authors may suggest not more than 3 referees working in the same area for evaluating the manuscript. However, the editorial board reserves the right to choose referees (even the one not suggested by the authors).

All manuscripts should be prepared according to a checklist based on ICMJE criteria. The checklist should be submitted with the manuscript as word file. Download checklist from here http://www.ejmanager.com/mnstemps/28/ICMJEchecklist.doc 

The editorial board may invite articles for review section from those with considerable standing in the field. However, such an invitation does not automatically guarantee their publication. These articles will also be subjected to review process and accepted only if found suitable. Authors must be careful when they reproduce text, tables or illustrations from other sources. Plagiarism will be viewed seriously. All accepted papers are subject to editorial changes.

Plagiarism Policy

Submission to TCR entails that authors automatically attest that none of the parts of manuscripts is plagiarized from any other source. Proper reference should be provided whenever anything is extracted from a source. Editoral assistants use Plagiarism detection softwares to ensure the originality of the article.

In the case of suspected plagiarism, Author will be issued a notice to defend the charge of plagiarism and after going through authors explanation if editorial board think that authors justification is not correct in that case board would take immediate and strict actions against the authors ranging from rejection of the manuscript to preclusion of the authors from any future publication in the journal. Journal will report to the authors/s affiliating institution about author’s misconduct.

Copyrights

Any article accepted for publication/published in the Clinical Researcher will be the copyright of the journal. The journal has the right to publish the accepted articles in any media (print, electronic or any other) any number of times. The authors should agree to transfer copyright and sign a declaration to this effect as per annexure 1.
 

Authorship

Each quoted author should have contributed substantially to the represented work in terms of conceptual design or analysis, writing of the article and final approval of the article in order to take public responsibility for the content. First-named authors must guarantee this to be so.

Conflicts of Interest

Authors must declare all conflicts of interest (or their absence) in their cover letter upon submission of a manuscript. This conflict declaration includes conflicts or potential conflicts of all listed authors. If any conflicts are declared, the journal will publish them with the paper. In cases of doubt, the circumstance should be disclosed so that the editors may assess its significance.Conflicts may be financial, academic, commercial, political or personal. Financial interests may include employment, research funding (received or pending), stock or share ownership, patents, payment for lectures or travel, consultancies, nonfinancial support, or any fiduciary interest in a company.

Ethics in Research

The Journals require author(s) at the time of manuscript submission to include a statement in the cover letter, indicating documented review and approval from a formally constituted review board (Institutional Review Board or Ethics committee) for all studies involving people, medical records, and human tissues, as per the uniform guidelines from the World Medical Association (www.wma.net/e/policy/b3.htm).

Types of Articles



Reviews, report on recent advances in clinical research.

Mini-Reviews discuss a more narrowly focused topic of recent research. Unsolicited reviews are considered only if they are authored by investigators who have demonstrated expertise in the relevant areas.

Original Research Papers contain innovative, hypothesis-driven research that is supported by sound experimental design, methodology, and data interpretation.

Short reports, normally more limited in scope than Original Research Papers, must be of high quality, general interest, and sufficient importance to warrant publication.

Rapid Communications provide a venue for fast-breaking research updates or other news items. The justification for rapid communication should be stated in the cover letter during submission.

Editorials, Commentaries & Summaries are usually published by invitation only. These articles contain topical issues of public and scientific interest.

Meeting Notices provide readers with information on an upcoming conferences/workshops etc., including title of the meeting, date, time, location, an outline and description of meeting topics, and a list of invited speakers. If possible, Meeting Notices should include contact information for the organizers and a URL to the meeting’s webpage. Meeting Notices should be submitted to the Editorial Office two to three months prior to the meeting.

Letters to the Editor may be submitted by readers commenting on articles already published by the Journal.

Submission of Manuscript



Manuscripts must be submitted by e-mail as attached files (in MS-Word format) only.
Emails: dineshbadyal@gmail.com or editortcr09@gmail.com

Undertaking

The manuscript must be submitted with a statement, signed by all the authors, regarding the originality, authorship and transfer of copyright as per the format given in Authors should keep their manuscripts as short as they reasonably can.

Recommended word counts are as follows: Reviews and Original Research Article: 5000; Mini Reviews and short reports: 2500; Others: 1200.

Manuscript Organization



Manuscripts should be typed double spaced on one side of good quality A4 size paper. Page number should appear in the upper right hand corner of each page, beginning with the title page.The language of manuscript must be simple and explicit. The authors who are not confident are advised to consult those experienced in scientific writing and communication.

It should be arranged into the following sections (for original research papers and short reports):

  1. Title page
  2. Abstract and Keywords
  3. Introduction
  4. Materials and Methods
  5. Results
  6. Discussion
  7. Acknowledgement
  8. References
  9. Tables
  10. Figures


1. Title Page

It should be paginated as page 1 of the paper. It should carry the title, authors’ names and their affiliations, running title, address for correspondence including e-mail address and also a list of number of pages, figures, tables and word count.

Title: Must be informative, specific and short and not exceed 150 characters.

Authors and affiliations: The names of authors (surname first followed by middle initial and full first name) and their appropriate addresses should be given. It should be made clear which address relates to which author.

Running title: It is a short title printed in the journal at the right top corner of right hand page of the article (except the lead page). A short running title of not more than 50 characters should be given.

Address for correspondence: The corresponding author’s address should be given in the title page. The fax number (if available) may be mentioned. The e-mail ID of the corresponding author must also be provided.

2. Abstracts and Keywords

Only Reviews, Mini Reviews, Original Research Articles and Short reports require an abstract. The abstract is limited to 250 words or less. For original Research Articles, the abstract should include a brief (2 to 3 sentences) statement for each of the following sections: Introduction, Methods and Materials, Results and Discussion, and Conclusion written in paragraph form. All abstracts must be written in one paragraph, with no subheadings, equations, tables, reference citations or graphics.

Keywords: Provide 3-5 keywords which will help readers or indexing agencies in cross-indexing the study. The words found in title need not be given as key words. Use terms from the latest Medical Subject Headings (MeSH) list of Index Medicus. A more general term may be used if a suitable MeSH term is not available.

3. Introduction

It should start on a new page. Give a concise background of the study. Do not review literature extensively but provide the most recent work that has a direct bearing on the subject. Justification for research aims and objectives must be clearly mentioned without any ambiguity. The purpose of the study should be stated at the end.

4. Material & Methods

This section should deal with the materials used and the methodology. The procedure adopted should be described in sufficient detail to allow the work to be interpreted and repeated by the readers, if necessary. The number of subjects, the number of groups studied, the study design, sources of drugs with dosage regimen or instruments used, statistical methods and ethical aspects must be mentioned under the section. The nomenclature, the source of material and equipment used, with details of the manufacturers in parentheses, should be clearly mentioned. Drugs and chemicals should be precisely identified using their non-proprietary names or generic names. If necessary, the proprietary or commercial name may be inserted once in parentheses. The first letter of the drug name should be small for generic name (e.g., dipyridamole, propranolol) but capitalized for proprietary names (e.g., Persantin, Inderal). New or uncommon drug should be identified by the chemical name and structural formula.

The doses of drugs should be given as unit weight per kilogram body weight e.g., mg/kg and the concentrations should be given in terms of molarity e.g., nm or mM.

5. Results

The results should be stated concisely without comments. It should be presented in logical sequence in the text with appropriate reference to tables and/or figures. The data given in tables or figures should not be repeated in the text. The same data should not be presented in both tabular and graphic forms. Simple data may be given in the text itself instead of figures or tables. Avoid discussions and conclusions in the results section.

6. Discussion

This section should deal with the interpretation of results, rather than recapitulation of results. It is important to discuss the new and significant observations in the light of previous work. Discuss also the weaknesses or pitfalls in the study. New hypotheses or recommendations can be put forth.

7. Acknoledgements

It should be typed in a new page. Acknowledge only persons who have contributed to the scientific content or provided technical support. Sources of financial support should be mentioned.

8. References

It should begin on a new page. The number of references should normally be restricted to a maximum of 20 for a review and original research paper and 10 in others. Majority of them should preferably be of articles published in the last 5 years. Avoid citing abstracts as references. References are to be cited in the text by superscribed number and should be in the order in which they appear. References cited only in tables or in legends to figures should be numbered in accordance with a sequence established by the first identification in the text of the particular table or illustration. The list of references should be typed double spaced following the Vancouver style. Examples are given in Annexure II.

9. Tables

Each table must be self-explanatory and presented in such a way that they are easily understandable without referring to the text. It should be typed with double spacing and numbered consecutively with Arabic numerals. Provide a short descriptive caption above each table with foot notes and/or explanations underneath. All significant results must be indicated using asterisks. Appropriate positions for the tables within the text may be indicated. Provide tables as far as possible in MS word format at the end of the manuscript.

10. Figures

Each figure must be numbered and a short descriptive caption must be provided. All significant results should be indicated using asterisks. Submit Legends for figures should be typed under the figure if possible or on a separate sheet.

Provide figures as far as possible in MS word format or MS excel or as good quality scanned images at the end of the manuscript.


Submission of Revised Manuscript



The authors should revise the manuscript immediately after receipt of the comments from the editorial office. A note mentioning the changes incorporated in the revised text as per referee’s comments (point by point) should be sent. The revised manuscript has to be submitted within 2 months; else the manuscript will be considered withdrawn by the authors.Calling for revision does not guarantee acceptance. Those revised manuscripts which underwent major revision are likely to be sent to referees for evaluation. If the authors have substantial reasons that their manuscript was rejected unjustifiably, they may request for reconsideration.

Proofs

Proofs will be sent to the corresponding author for final checking. It is the authors’ responsibility to go through the proof meticulously and correct errors if any. Correction should be restricted to printer’s error only and no substantial addition/deletion should be made. Proofs will be sent by e-mail, if the corresponding author has an e-mail address.

Disclaimer



Although every effort is made by the publishers and editorial board to see that no inaccurate or misleading data, opinion or statement appear in this on-line journal, they wish to make it clear that the data and opinions appearing in the articles and advertisements herein are the responsibility of the contributor or advertiser concerned. Accordingly, the publishers and the editorial board accept no liability whatsoever for the consequences of any such inaccurate or misleading data, opinion or statement. Whilst every effort is made to ensure that drug doses and other quantities are presented accurately, readers are advised that new methods and techniques involving drug usage, and described in this journal, should only be followed in conjunction with the drug manufacturer's own published literature.

Annexure



Example of references - Vancouver Style (from Uniform Requirements for Manuscripts, http://www.icmje.org)

Articles in Journals
Kumar KJ, Pina I, Krevsky B. Heart transplantation is associated with an increased risk for pancreatobiliary disease. Ann Intern Med 1996;124: 1180-3. More than six authors, list the first six authors followed by et al.:
Parker DM, Clayton D, Black RJ, Masuyer E, Friedl HP, James E, et al. Childhood leukaemia in Europe after Chernobyl: 5 year follow-up. Am J Cancer 1996;73:906-12.

Organization as author
The Cardiac Society of Australia and New Zealand. Clinical exercise stress testing. Safety and performance guidelines. Med J Aust 1996; 164: 282-4.

Volume with supplement
Shen HM, Zhang QF. Risk assess-ment of nickel carcinogenicity and occupational lung cancer. Environ Health Perspect 1994;102 Suppl 1:275-82.

Issue with supplement
Payne DK, Sullivan MD, Massie MJ. Women's psychological reactions to breast cancer. Semin Oncol 1996; 23(1 Suppl 2):89-97.

Volume with part
Ozben T, Nacitarhan S, Tuncer N. Plasma and urine sialic acid in non-insulin dependent diabetes mellitus. Ann Clin Biochem 1995;32(Pt 3):303-6.

Issue with part
Poole GH, Mills SM. One hundred consecutive cases of flap lacerations of the leg in ageing patients. N Z Med J 1994;107(986 Pt 1):377-8.

Issue with no volume
Turan I, Wredmark T, Fellander-Tsai L. Arthroscopic ankle arthrodesis in rheumatoid arthritis. Clin Orthop 1995;(320):110-4.

No issue or volume
Browell DA, Lennard TW. Immuno-logic status of the cancer patient and the effects of blood transfusion on antitumor responses. Curr Opin Gen Surg 1993:325-33.

Pagination in Roman numerals
Fisher GA, Sikic BI. Drug resistance in clinical oncology and hematology. Introduction. Hematol Oncol Clin North Am 1995 Apr;9(2):xi-xii.

Type of article indicated as needed
Enzensberger W, Fischer PA. Metronome in Parkinson's disease [letter]. Lancet 1996;347:1337. Clement J, De Bock R. Hematological complications of hantavirus nephro-pathy (HVN) [abstract]. Kidney Int 1992;42:1285.

Personal author(s)
Ringsven MK, Bond D. Gerontology and leadership skills for nurses. 2nd ed. Albany (NY): Delmar Publishers; 1996.

Editor(s), compiler(s) as author
Norman IJ, Redfern SJ, editors. Mental health care for elderly people. New York: Churchill Livingstone; 1996.

Organization as author and publisher
Institute of Medicine (US). Looking at the future of the Medicaid program. Washington: The Institute; 1992.

Chapter in a book
(Note: Previous Vancouver style had a colon rather than a p before pagination.) Phillips SJ, Whisnant JP. Hypertension and stroke. In: Laragh JH, Brenner BM, editors. Hyperten-sion: pathophysiology, diagnosis, and management. 2nd ed. New York: Raven Press; 1995. p. 465-78.

Conference proceedings
Kimura J, Shibasaki H, editors. Recent advances in clinical neuro-physiology. Proceedings of the 10th International Congress of EMG and Clinical Neurophysiology; 1995 Oct 15-19; Kyoto, Japan. Amsterdam: Elsevier; 1996.

Conference paper
Bengtsson S, Solheim BG. Enforce-ment of data protection, privacy and security in medical informatics. In: Lun KC, Degoulet P, Piemme TE, Rienhoff O, editors. MEDINFO 92. Procee-dings of the 7th World Congress on Medical Infor-matics; 1992 Sep 6-10; Geneva, Switzerland. Amsterdam: North-Holland; 1992. p. 1561-5.

Scientific or technical report
Issued by funding/sponsoring agency: Smith P, Golladay K. Payment for durable medical equipment billed during skilled nursing facility stays. Final report. Dallas (TX): Dept. of Health and Human Services (US), Office of Evaluation and Inspections; 1994 Oct. Report No.: HHSIGOEI69200860. Issued by performing agency: Field MJ, Tranquada RE, Feasley JC, editors. Health services research: work force and educational issues. Washington: National Academy Press; 1995. Contract No.: AHCPR282942008. Sponsored by the Agency for Health Care Policy and Research.

Dissertation
Kaplan SJ. Post-hospital home health care: the elderly's access and utilization [dissertation]. St. Louis (MO): Washington Univ.; 1995.

Patent
Larsen CE, Trip R, Johnson CR, in-ventors; Novoste Corporation, assignee. Methods for procedures re-lated to the electrophysiology of the heart. US patent 5,529,067. 1995 Jun 25. Other Published Material

Newspaper article
Lee G. Hospitalizations tied to ozone pollution: study estimates 50,000 admissions annually. The Washington Post 1996 Jun 21;Sect. A:3 (col. 5).

Audiovisual material HIV+/AIDS: the facts and the future [videocassette]. St. Louis (MO): Mosby-Year Book; 1995.

In press (Note: NLM prefers "forthcoming" because not all items will be printed.) Leshner AI. Molecular mechanisms of cocaine addiction. N Engl J Med. In press 1996.

Electronic Material: Journal article in electronic format Morse SS. Factors in the emergence of infectious diseases. Emerg Infect Dis [serial online] 1995 Jan-Mar [cited 1996 Jun 5];1(1):[24 screens]. Avai